The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Rapid Identification of Potential Inhibitors of SARS‐CoV‐2 Main Protease by Deep Docking of 1.3 Billion Compounds
Open accessAbstract
The recently emerged 2019 Novel Coronavirus (SARS‐CoV‐2) and associated COVID‐19 disease cause serious or even fatal respiratory tract infection and yet no approved therapeutics or effective treatment is currently available to effectively combat the outbreak. This urgent situation is pressing the world to respond with the development of novel vaccine or a small molecule therapeutics for SARS‐CoV‐2. Along these efforts, the structure of SARS‐CoV‐2 main protease (Mpro) has been rapidly resolved and made publicly available to facilitate global efforts to develop novel drug candidates. Recently, our group has developed a novel deep learning platform – Deep Docking (DD) which provides fast prediction of docking scores of Glide (or any other docking program) and, hence, enables structure‐based virtual screening of billions of purchasable molecules in a short time. In the current study we applied DD to all 1.3 billion compounds from ZINC15 library to identify top 1,000 potential ligands for SARS‐CoV‐2 Mpro protein. The compounds are made publicly available for further characterization and development by scientific community.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0306430 · Cited by 10,057
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Hui, D. S., I Azhar, E., Madani, T. A., Ntoumi, F., Kock, R., Dar, O., Ippolito, G., Mchugh, T. D., Memish, Z. A., Drosten, C., et al. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.01.009 · Cited by 3,809
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
ZINC 15 – Ligand Discovery for Everyone
Sterling, T., & Irwin, J. J. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00559 · Cited by 3,224
The Properties of Known Drugs. 1. Molecular Frameworks
Bemis, G. W., & Murcko, M. A. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9602928 · Cited by 2,482
Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking.
Mysinger, M. M., Carchia, M., Irwin, J. J., & Shoichet, B. K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300687e · Cited by 2,412
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl999 · Cited by 2,124
Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
Li, G., & De Clercq, E. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00016-0 · Cited by 1,729
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003) · Science · doi:10.1126/science.1085658 · Cited by 1,728
Coronaviruses — drug discovery and therapeutic options
Zumla, A., Chan, J. F. W., Azhar, E. I., Hui, D. S. C., & Yuen, K.-Y. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.37 · Cited by 1,707
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Chu, C. M. (2004) · Thorax · doi:10.1136/thorax.2003.012658 · Cited by 1,645
Hawkins, P. C. D., Skillman, A. G., Warren, G. L., Ellingson, B. A., & Stahl, M. T. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci100031x · Cited by 1,607
Software for molecular docking: a review
Pagadala, N. S., Syed, K., & Tuszynski, J. (2017) · Biophysical Reviews · doi:10.1007/s12551-016-0247-1 · Cited by 1,522
Targeting proteases: successes, failures and future prospects
Turk, B. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2092 · Cited by 1,363
From SARS to MERS, Thrusting Coronaviruses into the Spotlight
Song, Z., Xu, Y., Bao, L., Zhang, L., Yu, P., Qu, Y., Zhu, H., Zhao, W., Han, Y., & Qin, C. (2019) · Viruses · doi:10.3390/v11010059 · Cited by 1,265
Ultra-large library docking for discovering new chemotypes
Lyu, J., Wang, S., Balius, T. E., Singh, I., Levit, A., Moroz, Y. S., O’Meara, M. J., Che, T., Algaa, E., Tolmachova, K., et al. (2019) · Nature · doi:10.1038/s41586-019-0917-9 · Cited by 998
Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1835675100 · Cited by 990
Gordon, C. J., Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.013056 · Cited by 850
Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S.-H. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01461 · Cited by 775
Protein–Ligand Scoring with Convolutional Neural Networks
Ragoza, M., Hochuli, J., Idrobo, E., Sunseri, J., & Koes, D. R. (2017) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6b00740 · Cited by 774
Key Topics in Molecular Docking for Drug Design
Torres, P. H. M., Sodero, A. C. R., Jofily, P., & Silva-Jr, F. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184574 · Cited by 641
Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines
Liu, X., & Wang, X.-J. (2020) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.02.001 · Cited by 464
Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery
Gentile, F., Agrawal, V., Hsing, M., Ton, A.-T., Ban, F., Norinder, U., Gleave, M. E., & Cherkasov, A. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00229 · Cited by 447
Self-citationInteractions between Bacteriophage, Bacteria, and the Mammalian Immune System
Van Belleghem, J. D., Dąbrowska, K., Vaneechoutte, M., Barr, J. J., & Bollyky, P. L. (2018) · Viruses · doi:10.3390/v11010010 · Cited by 408
Xu, Z., Shi, D., Han, J.-B., Ling, Y., Jiang, X., Lu, X., Li, C., Gong, L., Ge, G., Zhang, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01429-0 · Cited by 301
SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
Muramatsu, T., Takemoto, C., Kim, Y.-T., Wang, H., Nishii, W., Terada, T., Shirouzu, M., & Yokoyama, S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1601327113 · Cited by 274
Annual Reports in Medicinal Chemistry, 1965.
Burger, A. (1967) · Journal of Medicinal Chemistry · doi:10.1021/jm00316a057 · Cited by 235
Han, D. P., Penn-Nicholson, A., & Cho, M. W. (2006) · Virology · doi:10.1016/j.virol.2006.01.029 · Cited by 214
High-Throughput Screening Identifies Inhibitors of the SARS Coronavirus Main Proteinase
Blanchard, J. E., Elowe, N. H., Huitema, C., Fortin, P. D., Cechetto, J. D., Eltis, L. D., & Brown, E. D. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.08.011 · Cited by 206
Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors
Chen, L.-R., Wang, Y.-C., Lin, Y. W., Chou, S.-Y., Chen, S.-F., Liu, L. T., Wu, Y.-T., Kuo, C.-J., Chen, T. S.-S., & Juang, S.-H. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.04.027 · Cited by 180
The Taxonomy of Covalent Inhibitors
Tuley, A., & Fast, W. L. (2018) · Biochemistry · doi:10.1021/acs.biochem.8b00315 · Cited by 167
Lu, I.-L., Mahindroo, N., Liang, P.-H., Peng, Y.-H., Kuo, C.-J., Tsai, K.-C., Hsieh, H.-P., Chao, Y.-S., & Wu, S.-Y. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060207o · Cited by 161
Cameron, C. E., & Castro, C. D. (2001) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200112000-00015 · Cited by 147
Ghosh, A. K., Gong, G., Grum-Tokars, V. L., Mulhearn, D. C., Baker, S. C., Coughlin, M. M., Prabhakar, B. S., Sleeman, K., Johnson, M. E., & Mesecar, A. D. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.082 · Cited by 137
Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput ScreeningPreprint
Li, Y., Zhang, J., Wang, N., Li, H., Shi, Y., Guo, G., Liu, K., Zeng, H., & Zou, Q. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.01.28.922922 · Cited by 128
Turlington, M., Chun, A. C., Tomar, S., Eggler, A. L., Grum-Tokars, V. L., Jacobs, J., Daniels, J. S., Dawson, E. S., Saldanha, A., Chase, P. S., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.112 · Cited by 125
Chaput, L., Martinez‐Sanz, J., Saettel, N., & Mouawad, L. (2016) · Journal of Cheminformatics · doi:10.1186/s13321-016-0167-x · Cited by 122
Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov
Zhang, H., Saravanan, K. M., Yang, Y., Hossain, M. T., Li, J., Ren, X., Pan, Y., & Wei, Y. (2020) · Interdisciplinary Sciences: Computational Life Sciences · doi:10.1007/s12539-020-00376-6 · Cited by 122
Coronavirus 3CL pro proteinase cleavage sites: Possible relevance to SARS virus pathology
Kiemer, L., Lund, O., Brunak, S., & Blom, N. (2004) · BMC Bioinformatics · doi:10.1186/1471-2105-5-72 · Cited by 110
DeepBindRG: a deep learning based method for estimating effective protein–ligand affinity
Zhang, H., Liao, L., Saravanan, K. M., Yin, P., & Wei, Y. (2019) · PeerJ · doi:10.7717/peerj.7362 · Cited by 107
Liu, W., Zhu, H.-M., Niu, G.-J., Shi, E.-Z., Chen, J., Sun, B., Chen, W., Zhou, H., & Yang, C. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.028 · Cited by 98
Paasche, A., Zipper, A., Schäfer, S., Ziebuhr, J., Schirmeister, T., & Engels, B. (2014) · Biochemistry · doi:10.1021/bi400604t · Cited by 87
Ashtawy, H. M., & Mahapatra, N. R. (2014) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2014.2351824 · Cited by 82
Design and Validation of Novel Chikungunya Virus Protease Inhibitors
Das, P. K., Puusepp, L., Varghese, F. S., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01421-16 · Cited by 77
Shah, F., Mukherjee, P. K., Gut, J., Legac, J., Rosenthal, P. J., Tekwani, B. L., & Avery, M. A. (2011) · Journal of Chemical Information and Modeling · doi:10.1021/ci200029y · Cited by 70
Berry, M. J., Fielding, B. C., & Gamieldien, J. (2015) · Viruses · doi:10.3390/v7122963 · Cited by 68
Lee, H., Mittal, A., Patel, K., Gatuz, J. L., Truong, L., Torres, J., Mulhearn, D. C., & Johnson, M. E. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.11.041 · Cited by 62
Progress in Anti-SARS Coronavirus Chemistry, Biology and Chemotherapy
Ghosh, A. K., Xi, K., Johnson, M. E., Baker, S. C., & Mesecar, A. D. (2006) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(06)41011-3 · Cited by 58
Coronavirus: the first three months as it happened
(2020) · Nature · doi:10.1038/d41586-020-00154-w · Cited by 54
Das, M. K., Arya, R. K., Debnath, S., Debnath, R., Lodh, A., Bishwal, S. C., Das, A., & Nanda, R. K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02586-15 · Cited by 25
Cited by
Computational approaches streamlining drug discovery
Sadybekov, A. V., & Katritch, V. (2023) · Nature · doi:10.1038/s41586-023-05905-z · Cited by 1,279
Naqvi, A. A. T., Fatima, K., Mohammad, T., Fatima, U., Singh, I. K., Singh, A., Atif, S. M., Hariprasad, G., Hasan, G. M., & Hassan, M. I. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165878 · Cited by 1,114
Sabe, V. T., Ntombela, T., Jhamba, L. A., Maguire, G. E. M., Govender, T., Naicker, T., & Kruger, H. G. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113705 · Cited by 625
Drug repurposing approach to fight COVID-19
Singh, T. U., Parida, S., Lingaraju, M. C., Kesavan, M., Kumar, D., & Singh, R. K. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00155-6 · Cited by 480
Gentile, F., Yaacoub, J. C., Gleave, J., Fernandez, M., Ton, A.-T., Ban, F., Stern, A., & Cherkasov, A. (2022) · Nature Protocols · doi:10.1038/s41596-021-00659-2 · Cited by 397
Self-citation
Metadata
- Authors
- Ton, A., Gentile, F., Hsing, M., Ban, F., & Cherkasov, A.
- Venue
- Molecular Informatics
- Publisher
- Wiley
- Published
- 2020-03-23
- Volume
- 39
- Issue
- 8
- Pages
- e2000028-e2000028
- ISSN
- 1868-1743 (ISSN-L)
- 1868-1751
- OpenAlex
- W3009970748
- Cited by
- 517
- References
- 53
- FWCI
- 52.89
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.